Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shimin Xu

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Bioorganic & Medicinal Chemistry Letters|May 6, 2004
N-Aryl-gamma-lactams as integrin alphavbeta3 antagonistsNing Xi, Stephen Arvedson, Shawn Eisenberg, et al.
Journal of Medicinal Chemistry|June 9, 2006
Design of potent, orally available antagonists of the transient receptor potential vanilloid 1. Structure-activity relationships of 2-piperazin-1-yl-1H-benzimidazolesVassil I Ognyanov, Chenera Balan, Anthony W Bannon, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Melanocortin subtype-4 receptor agonists containing a piperazine core with substituted aryl sulfonamidesChristopher Fotsch, Nianhe Han, Premilla Arasasingham, et al.
Journal of Medicinal Chemistry|September 27, 2008
3-amino-7-phthalazinylbenzoisoxazoles as a novel class of potent, selective, and orally available inhibitors of p38alpha mitogen-activated protein kinaseLiping H Pettus, Shimin Xu, Guo-Qiang Cao, et al.
Journal of Medicinal Chemistry|March 3, 2012
Discovery of highly potent and selective pan-Aurora kinase inhibitors with enhanced in vivo antitumor therapeutic indexGang Liu, Sunny Abraham, Lan Tran, et al.
Journal of Medicinal Chemistry|September 27, 2008
Discovery of highly selective and potent p38 inhibitors based on a phthalazine scaffoldBrad Herberich, Guo-Qiang Cao, Partha P Chakrabarti, et al.
Journal of Medicinal Chemistry|September 4, 2008
Design, synthesis, and biological evaluation of potent c-Met inhibitorsNoel D D'Angelo, Steven F Bellon, Shon K Booker, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Bioorganic & Medicinal Chemistry Letters|May 6, 2004
N-Aryl-gamma-lactams as integrin alphavbeta3 antagonistsNing Xi, Stephen Arvedson, Shawn Eisenberg, et al.
Journal of Medicinal Chemistry|June 9, 2006
Design of potent, orally available antagonists of the transient receptor potential vanilloid 1. Structure-activity relationships of 2-piperazin-1-yl-1H-benzimidazolesVassil I Ognyanov, Chenera Balan, Anthony W Bannon, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Melanocortin subtype-4 receptor agonists containing a piperazine core with substituted aryl sulfonamidesChristopher Fotsch, Nianhe Han, Premilla Arasasingham, et al.
Journal of Medicinal Chemistry|September 27, 2008
3-amino-7-phthalazinylbenzoisoxazoles as a novel class of potent, selective, and orally available inhibitors of p38alpha mitogen-activated protein kinaseLiping H Pettus, Shimin Xu, Guo-Qiang Cao, et al.
Journal of Medicinal Chemistry|March 3, 2012
Discovery of highly potent and selective pan-Aurora kinase inhibitors with enhanced in vivo antitumor therapeutic indexGang Liu, Sunny Abraham, Lan Tran, et al.
Journal of Medicinal Chemistry|September 27, 2008
Discovery of highly selective and potent p38 inhibitors based on a phthalazine scaffoldBrad Herberich, Guo-Qiang Cao, Partha P Chakrabarti, et al.
Journal of Medicinal Chemistry|September 4, 2008
Design, synthesis, and biological evaluation of potent c-Met inhibitorsNoel D D'Angelo, Steven F Bellon, Shon K Booker, et al.
Pageof 4